We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00144898
First Posted: September 5, 2005
Last Update Posted: July 29, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Hospices Civils de Lyon
  Purpose

Sentinel node resection appears as a promising advancement in the surgical treatment of breast cancer.

The GF-GS 01 study, sponsored by a National Hospital Research Program, compares this new surgical method with a classical method in patients having a negative sentinel node.

The duration of the follow-up is 5 years.


Condition Intervention Phase
Breast Cancer Procedure: Sentinel Node Resection Procedure: Conventional Axillary Dissection Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized, Phase III Clinical Trial GF-GS 01 to Compare Conventional Axillary Dissection Versus Sentinel Node Resection (GS) in Clinically Node-negative Operable Breast Cancer Unifocal N0 Patients

Resource links provided by NLM:


Further study details as provided by Hospices Civils de Lyon:

Primary Outcome Measures:
  • Survival without recurrence [ Time Frame: 5 years ]

Enrollment: 1627
Study Start Date: July 2003
Study Completion Date: June 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Sentinel Node Resection
Sentinel Node Resection
Procedure: Sentinel Node Resection
Sentinel Node Resection
Conventional Axillary Dissection
Conventional Axillary Dissection
Procedure: Conventional Axillary Dissection
Conventional Axillary Dissection

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Women older than 18 years with clinically node-negative operable unifocal N0 breast cancer (clinical tumour size < 30 mm).
  • Written consent is obtained from all patients before randomization.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00144898


Locations
France
Alain LEIZOROVICZ
Lyon, France, 69376
Sponsors and Collaborators
Hospices Civils de Lyon
Investigators
Principal Investigator: Gilles HOUVENAEGHEL, MD Institut Paoli Calmette
  More Information

Responsible Party: Hospices Civils de Lyon
ClinicalTrials.gov Identifier: NCT00144898     History of Changes
Other Study ID Numbers: 2003.312
First Submitted: September 2, 2005
First Posted: September 5, 2005
Last Update Posted: July 29, 2013
Last Verified: July 2013

Keywords provided by Hospices Civils de Lyon:
Breast cancer
sentinel node resection
survival
Breast cancer unifocal N0

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases